Association of oxidative stress with realgar-induced differentiation in human leukemia HL-60 cells

Chemotherapy

Volumn 55, Issue 6, 2009, Pages 460-467

  Wang, Li Wen ^a   Shi, Yan Ling ^a   Wang, Nan ^b   Gou, Bao Di ^b   Zhang, Tian Lan ^a,b   Wang, Kui ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Differentiation; HL 60; Mitochondrion transmembrane potential; Oxidative stress; Realgar

Indexed keywords

ARSENIC DERIVATIVE; ARSENIC SULFIDE; CATALASE; CD11B ANTIGEN; GLUTATHIONE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; REALGAR; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NITROBLUE TETRAZOLIUM TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ANTIGENS, CD11B; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CELL CYCLE; CELL DIFFERENTIATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GLUTATHIONE; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SULFIDES; TIME FACTORS;

EID: 71249157722     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265528     Document Type: Article

References (42)

1. Tsiftsoglou AS, Pappas IS, Vizirianakis IS: Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol Ther 2003; 100: 257-290.
2. Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, et al: Use of arsenic trioxide (As 2 O 3 ) in the treatment of acute promyelocytic leukemia (APL). I. As 2 O 3 exerts dose-dependent dual effects on APL cells. Blood 1997; 89: 3345-3353. (Pubitemid 27229821)
3. Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, et al: Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 2000; 14: 262-270.
4. Gianni M, Ponzanelli I, Mologni L, Reichert U, Rambaldi A, Terao M, et al: Retinoiddependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Cell Death Differ 2000; 7: 447-460.
5. Chandra J, Samali A, Orrenius S: Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000; 29: 323-333.
6. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
7. England K, O'Driscoll C, Cotter TG: Carbonylation of glycolytic proteins is a key response to drug-induced oxidative stress and apoptosis. Cell Death Differ 2004; 11: 252-260.
8. Magi B, Ettorre A, Liberatori S, Bini L, Andreassi M, Frosali S, et al: Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death Differ 2004; 11: 842-852.
9. Covacci V, Torsello A, Palozza P, Sgambato A, Romano G, Boninsegna A, et al: DNA oxidative damage during differentiation of HL-60 human promyelocytic leukemia cells. Chem Res Toxicol 2001; 14: 1492-1497.
10. Ding W, Hudson LG, Liu KJ: Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol Cell Biochem 2005; 279: 105-112.
11. Shackelford RE, Kaufmann WK, Paules RS: Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 2000; 28: 1387-1404.
12. Stefano AD, Frosali S, Leonini A, Ettorre A, Priora R, Simplicio FCD, et al: GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. Biochim Biophys Acta 2006; 1763: 214-225.
13. Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR, et al: Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 2002; 99: 3136-3143.
14. The Cooperation Group: Phase II clinical trial of compound Huangdai tablet in newly diagnosed acute promyelocytic leukemia. Chin J Hematol 2006; 27: 801-804.
15. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, et al: Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 2008; 105: 4826-4831.
16. Luo LY, Huang J, Gou BD, Zhang TL, Wang K: Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by arsenic sulphide: involvement of serine/threonine protein phosphatases. Leuk Res 2006; 30: 1399-1405.
17. Wang N, Wang LW, Gou BD, Zhang TL, Wang K: Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells. Cell Biol Int 2008; 32: 1497-1505.
18. Muranaka S, Fujita H, Fujiwara T, Ogino T, Sato EF, Akiyama J, et al: Mechanism and characteristics of stimuli-dependent ROS generation in undifferentiated HL-60 cells. Antioxid Redox Signal 2005; 7: 1367-1376.
19. Wang J, Li LN, Cang H, Shi GY, Yi J: NADPH oxidase-derived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells. Leuk Res 2008; 32: 429-436.
20. Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV: Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci USA 2004; 101: 4578-4583.
21. Yamamoto T, Sakaguchi N, Hachiya M, Nakayama F, Yamakawa M, Akashi M: Role of catalase in monocytic differentiation of U937 cells by TPA: hydrogen peroxide as a second messenger. Leukemia 2009; 23: 761-769.
22. Hachiya M, Akashi M: Catalase regulates cell growth in HL60 human promyelocyt ic cells: evidence for growth regulation by H 2 O 2 . Radiat Res 2005; 163: 271-282.
23. Choi WY, Kim GY, Lee WH, Choi YH: Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy 2008; 54: 279-287.
24. Narang VS, Pauletti GM, Gout PW, Buckley DJ, Buckley AR: Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of doxorubicin. Chemotherapy 2007; 53: 210-217.
25. Ko CH, Shen SC, Hsu CS, Chen YC: Mitochondrial- dependent, reactive oxygen species- independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. Biochem Pharmacol 2005; 69: 913-922.
26. Lenoble V, Delucha V, Serpaud B, Bollinger JC: Arsenite oxidation and arsenate determination by the molybdene blue method. Talanta 2003; 61: 267-276.
27. Treumer J, Valet G: Flow-cytometric determination of glutathione alterations in vital cells by o-phthaldialdehyde (OPT) staining. Exp Cell Res 1986; 163: 518-524.
28. Ettorre A, Andreassi M, Anselmi C, Neri P, Andreassi L, Stefano DA: Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes. J Invest Dermatol 2003; 121: 328-336.
29. Kumagai Y, Sumi D: Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol 2007; 47: 243-262.
30. Plantin-Carrenard E, Bernard M, Derappe C, Bringuier A, Vadrot N, Feldmann G, et al: Differential responses of proliferative and non-proliferative leukemia cells to oxidative stress. Free Radic Res 2005; 39: 1-13.
31. Inayat-Hussain SH, Osman AB, Din LB, Taniguchi N: Altholactone, a novel styryllactone, induces apoptosis via oxidative stress in human HL-60 leukemia cells. Toxicol Lett 2002; 131: 153-159.
32. Chénais B, Andriollo M, Guiraud P, Belhoussine R, Jeannesson P: Oxidative stress involvement in chemically induced differentiation of K562 cells. Free Radic Biol Med 2000; 28: 18-27.
33. Mody N, Parhami F, Sarafian TA, Demer LL: Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001; 31: 509-519.
34. Brown G, Drayson MT, Durham J, Toellner KM, Hughes PJ, Choudhry MA, et al: HL60 cells halted in G1 or S phase differentiate normally. Exp Cell Res 2002; 281: 28-38.
35. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-247.
36. Matsuzawa A, Ichijo H: Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta 2008; 1780: 1325-1336.
37. Temple MD, Perrone GG, Dawes IW: Complex cellular responses to reactive oxygen species. Trends Cell Biol 2005; 15: 319-326
38. Fernandes PN, Mannarino SC, Silva CG, Pereira MD, Panek AD, Eleutherio ECA: Oxidative stress response in eukaryotes: effect of glutathione, superoxide dismutase and catalase on adaptation to peroxide and menadione stress in Saccharomyces cerevisiae . Redox Rep 2007; 12: 236-244.
39. Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML: A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 2004; 198: 327-335.
40. Hou DX, Uto T, Tong XH, Takeshita T, Tanigawa S, Imamura I, et al: Involvement of reactive oxygen species-independent mitochondrial pathway in gossypol-induced apoptosis. Arch Biochem Biophys 2004; 428: 179-187.
41. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, et al: The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998; 1366: 177-196. (Pubitemid 28467031)
42. Ralph SJ: Arsenic-based antineoplastic drugs and their mechanisms of action. Metal- Based Drugs 2008. DOI: 10.1155/2008/ 260146. (Pubitemid 351697080)